ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 26 filers reported holding ARGOS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | -100.0% | 750 | -88.1% | 0.00% | – |
| Q2 2017 | $2,000 | -50.0% | 6,306 | -28.8% | 0.00% | – |
| Q1 2017 | $4,000 | -75.0% | 8,853 | +185.5% | 0.00% | – |
| Q4 2016 | $16,000 | +45.5% | 3,101 | +35.9% | 0.00% | – |
| Q3 2016 | $11,000 | +450.0% | 2,281 | +597.6% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 327 | +9.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | -95.0% | 300 | -85.0% | 0.00% | – |
| Q3 2014 | $20,000 | -85.1% | 2,000 | -88.0% | 0.00% | – |
| Q2 2014 | $134,000 | – | 16,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
| Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
| SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
| WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
| Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
| WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 157,707 | $71,000 | 0.00% |
| SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
| BlackRock Inc. | 795,101 | $360,000 | 0.00% |